Literature DB >> 13460894

Timed disintegration medication; need for more quantitative criteria.

J A CAMPBELL, D G CHAPMAN, L G CHATTEN.   

Abstract

Keywords:  TABLETS

Mesh:

Substances:

Year:  1957        PMID: 13460894      PMCID: PMC1824434     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Timed-disintegration capsules (TYMCAPS); a further study: an in vivo roentgenographic study, blood-level study and relief of anginal pain with pentaerythritol tetranitrate.

Authors:  T M FEINBLATT; E A FERGUSON
Journal:  N Engl J Med       Date:  1957-02-21       Impact factor: 91.245

2.  Physiological availability of drugs in tablets.

Authors:  J A CAMPBELL; D G CHAPMAN; L G CHATTEN
Journal:  Can Med Assoc J       Date:  1957-01-15       Impact factor: 8.262

3.  Timed-disintegration capsules; an in vivo roentgenographic study.

Authors:  T M FEINBLATT; E A FERGUSON
Journal:  N Engl J Med       Date:  1956-05-17       Impact factor: 91.245

  3 in total
  4 in total

1.  EVALUATION OF SUSTAINED-RELEASE ACETAZOLAMIDE.

Authors:  C MESTRE; M A GALIN; J M MCLEAN
Journal:  Br J Ophthalmol       Date:  1963-01       Impact factor: 4.638

2.  Criteria for oral sustained release medication with particular reference to amphetamine.

Authors:  J A CAMPBELL; E NELSON; D G CHAPMAN
Journal:  Can Med Assoc J       Date:  1959-07-01       Impact factor: 8.262

3.  Sustained release of drugs in certain drug-resin complexes as judged by urinary excretion rates.

Authors:  D G CHAPMAN; K G SHENOY; J A CAMPBELL
Journal:  Can Med Assoc J       Date:  1959-09-05       Impact factor: 8.262

4.  Timed-Release Preparations for Oral Medication.

Authors:  J A Campbell
Journal:  Can Med Assoc J       Date:  1959-03-15       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.